{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:44:44Z","timestamp":1783547084718,"version":"3.55.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pericardial effusion (PE) is a known complication after hematopoietic stem cell transplant (HSCT). Limited data is currently available regarding the incidence and outcomes of PE in pediatric HSCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We conducted a retrospective study on a cohort of patients who underwent HSCT between 2004 and 2015. Risk factors associated with development of PE were evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In 111 HSCT, stem cell source was bone marrow in 37 (33.3%), peripheral blood\u201442 (37.8%) and cord blood\u201432 (28.8%). Incidence of PE after HSCT was 37.8%. Insignificant effusion (trivial or small) was noted in 30 (27.0%) transplants, and significant (moderate or large) PE in 12 (10.8%). There were no associations between incidence of effusion and stem cell source, graft versus host disease or CMV infection. Risk factors associated with development of PE included systemic hypertension (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05), total body irradiation (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05), and sinusoidal obstruction syndrome formerly known as venoocclusive disease (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.03). Overall mortality was 22.5% after HSCT, but 38.1% among those with effusion (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05). None of these deaths were attributed to primary cardiac etiologies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The incidence of PE in this cohort of pediatric HSCT recipients is high and associated with higher morbidity and mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000000974","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T21:48:40Z","timestamp":1506116920000},"page":"132-136","source":"Crossref","is-referenced-by-count":20,"title":["Incidence and Outcome of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplant: A Single-institution Experience"],"prefix":"10.1097","volume":"40","author":[{"given":"Melissa","family":"Diamond","sequence":"first","affiliation":[{"name":"Division of Pediatric Cardiology"},{"name":"Holtz Children\u2019s Hospital, Jackson Memorial Medical Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Ruiz-Mesa","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology"},{"name":"Holtz Children\u2019s Hospital, Jackson Memorial Medical Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando F.","family":"Corrales-Medina","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology"},{"name":"Holtz Children\u2019s Hospital, Jackson Memorial Medical Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo J.","family":"Tamariz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Biostatistics, University of Miami, Miller School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Ziga","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology"},{"name":"Holtz Children\u2019s Hospital, Jackson Memorial Medical Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sethuraman","family":"Swaminathan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology"},{"name":"Holtz Children\u2019s Hospital, Jackson Memorial Medical Center, Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","first-page":"213","article-title":"Pericardial effusion following conditioning for bone marrow transplantation in acute leukemia","volume":"2","author":"Veys","year":"1987","journal-title":"Bone Marrow Transplant"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bmt.2010.149","article-title":"Pericardial effusion post-SCT in pediatric patients with signs and\/or symptoms of cardiac disease","volume":"46","author":"Neier","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/petr.12062","article-title":"Pericardial effusion after pediatric hematopoietic cell transplant","volume":"17","author":"Aldoss","year":"2013","journal-title":"Pediatr Transplant"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/bmt.2010.345","article-title":"Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT","volume":"46","author":"Daly","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1705652","article-title":"Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT pediatric diseases and late effects working parties","volume":"39","author":"Uderzo","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/hrt.2007.136093","article-title":"Anthracycline associated cardiotoxicity in survivors of childhood cancer","volume":"94","author":"Lipshultz","year":"2008","journal-title":"Heart"},{"key":"R9-20230918","first-page":"44","article-title":"BCNU toxicity presenting with a large pericardial and pleural effusion","volume":"13","author":"Krishnan","year":"2008","journal-title":"Ann Transplant"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.bmt.1705023","article-title":"Pericardial effusion and cardiac tamponade in pediatric stem cell transplant","volume":"36","author":"Rhodes","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R11-20230918","first-page":"207","article-title":"Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease","volume":"17","author":"Seber","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0140-6736(92)91343-7","article-title":"Sudden cardiac tamponade after chemotherapy for marrow transplantation in thalassaemia","volume":"339","author":"Angelucci","year":"1992","journal-title":"Lancet"},{"key":"R13-20230918","first-page":"60","article-title":"A case of cardiac localization of graft-versus-host-disease after allogenic bone marrow transplantation","volume":"4","author":"Cereda","year":"2003","journal-title":"Ital Heart J"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701082","article-title":"Hemolytic uremic syndrome after allogenic or autologous hematopoietic stem cell transplantation for childhood malignancies","volume":"21","author":"Kondo","year":"1998","journal-title":"Bone Marrow Transplant"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201803000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:16:00Z","timestamp":1695010560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201803000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000000974","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}